323 related articles for article (PubMed ID: 20367535)
1. Medical management of polymyalgia rheumatica.
Gonzalez-Gay MA; Agudo M; Martinez-Dubois C; Pompei O; Blanco R
Expert Opin Pharmacother; 2010 May; 11(7):1077-87. PubMed ID: 20367535
[TBL] [Abstract][Full Text] [Related]
2. [Polymyalgia rheumatica: new possibilities for treatment, but not diagnosis].
Lems WF; Bijlsma JW
Ned Tijdschr Geneeskd; 2010; 154():A2048. PubMed ID: 20482925
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M; Dababneh A; Hajeer A; Ollier WE
J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
Gonzalez-Gay MA; Garcia-Porrua C; Salvarani C; Olivieri I; Hunder GG
J Rheumatol; 2000 Sep; 27(9):2179-84. PubMed ID: 10990231
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study.
Ferraccioli G; Salaffi F; De Vita S; Casatta L; Bartoli E
J Rheumatol; 1996 Apr; 23(4):624-8. PubMed ID: 8730115
[TBL] [Abstract][Full Text] [Related]
6. Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica Is Uncommon but May Be Enhanced by Amino Bisphosphonates.
Giollo A; Rossini M; Bettili F; Ghellere F; Fracassi E; Idolazzi L; Gatti D; Viapiana O
J Rheumatol; 2019 Mar; 46(3):318-322. PubMed ID: 30385701
[TBL] [Abstract][Full Text] [Related]
7. Treatment of polymyalgia rheumatica: a systematic review.
Hernández-Rodríguez J; Cid MC; López-Soto A; Espigol-Frigolé G; Bosch X
Arch Intern Med; 2009 Nov; 169(20):1839-50. PubMed ID: 19901135
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
Bahlas S; Ramos-Remus C; Davis P
J Rheumatol; 1998 Jan; 25(1):99-104. PubMed ID: 9458211
[TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study.
Catanoso MG; Macchioni P; Boiardi L; Pipitone N; Salvarani C
Arthritis Rheum; 2007 Dec; 57(8):1514-9. PubMed ID: 18050171
[TBL] [Abstract][Full Text] [Related]
10. The use of methotrexate in polymyalgia rheumatica.
Feinberg HL; Sherman JD; Schrepferman CG; Dietzen CJ; Feinberg GD
J Rheumatol; 1996 Sep; 23(9):1550-2. PubMed ID: 8877923
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids.
Cimmino MA; Salvarani C; Macchioni P; Gerli R; Bartoloni Bocci E; Montecucco C; Caporali R;
Clin Exp Rheumatol; 2008; 26(3):395-400. PubMed ID: 18578959
[TBL] [Abstract][Full Text] [Related]
12. Predicting the risk of relapse in polymyalgia rheumatica: novel insights.
Prieto-Peña D; Castañeda S; Atienza-Mateo B; Blanco R; González-Gay MA
Expert Rev Clin Immunol; 2021 Mar; 17(3):225-232. PubMed ID: 33570454
[TBL] [Abstract][Full Text] [Related]
13. Relapse in a population based cohort of patients with polymyalgia rheumatica.
Kremers HM; Reinalda MS; Crowson CS; Zinsmeister AR; Hunder GG; Gabriel SE
J Rheumatol; 2005 Jan; 32(1):65-73. PubMed ID: 15630727
[TBL] [Abstract][Full Text] [Related]
14. Polymyalgia rheumatica and giant cell arteritis.
Unwin B; Williams CM; Gilliland W
Am Fam Physician; 2006 Nov; 74(9):1547-54. PubMed ID: 17111894
[TBL] [Abstract][Full Text] [Related]
15. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory diseases in older adults: polymyalgia rheumatica.
Spiera R; Spiera H
Geriatrics; 2004 Nov; 59(11):39-43; quiz 44. PubMed ID: 15615159
[TBL] [Abstract][Full Text] [Related]
17. [Polymyalgia rheumatica and temporal arteritis].
Vos PA; Bijlsma JW; Derksen RH
Ned Tijdschr Geneeskd; 2005 Aug; 149(35):1932-7. PubMed ID: 16159030
[TBL] [Abstract][Full Text] [Related]
18. Polymyalgia rheumatica.
Salvarani C; Cantini F; Boiardi L; Hunder GG
Best Pract Res Clin Rheumatol; 2004 Oct; 18(5):705-22. PubMed ID: 15454128
[TBL] [Abstract][Full Text] [Related]
19. Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
Devauchelle-Pensec V; Carvajal-Alegria G; Dernis E; Richez C; Truchetet ME; Wendling D; Toussirot E; Perdriger A; Gottenberg JE; Felten R; Fautrel BJ; Chiche L; Hilliquin P; Le Henaff C; Dervieux B; Direz G; Chary-Valckenaere I; Cornec D; Guellec D; Marhadour T; Nowak E; Saraux A
JAMA; 2022 Sep; 328(11):1053-1062. PubMed ID: 36125471
[TBL] [Abstract][Full Text] [Related]
20. [Polymyalgia rheumatica and temporal arteritis. Observations on prognosis and treatment].
Auquier L; Paolaggi JB
Bull Acad Natl Med; 1990 Feb; 174(2):263-70; discussion 270-3. PubMed ID: 2372721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
